Identification of ZIC2 as a Potential Biomarker Linked with the Clinical Progression and Immune Infiltration of Oral Cancer: A Multicenter Study

Figure 12

Drug sensitivity of oral cancer patients with high or low expression of ZIC2 to two compounds: (a) box plot of sensitivity scores predicted for ERK_2240; box plot of sensitivity scores predicted for AZD8186.

(a)

(b)